Leverkusen, July 14, 2015 – Bayer HealthCare announced today that Gadovist® (gadobutrol) has received a label extension in the European Union (EU) for diagnostic use with magnetic resonance imaging ...
The FINANCIAL — Bayer HealthCare received approval in Japan for Gadovist (gadobutrol) injection for use with magnetic resonance imaging (MRI). Gadovist is the first high concentration/high relaxivity ...
The launch of Pixxoscan expands GE HealthCare’s portfolio of Magnetic Resonance Imaging (MRI) contrast agents, now offering two leading macrocyclic molecules to customers - Clariscan (gadoteric acid) ...
The US Food and Drug Administration has approved the gadolinium-based magnetic-resonance (MR) imaging contrast agent gadobutrol (Gadavist/Gadovist, Bayer) for myocardial perfusion studies in adults ...
Depending on the thermodynamic complex stability, addition of the trivalent metal salts may cause transmetallation or recomplexing in the MRI contrast agents, resulting in the release of toxic Gd 3+ ...
Healthy tissues can be distinguished from diseased tissues with the help of a highly detailed image of the organs provided by non-invasive diagnostics that make use of contrast agents. The functioning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results